Shire PLC (SHP.L)
Latest Key Developments (Source: Significant Developments)
Sept 21 (Reuters) - Shire PLC
Sept 13 (Reuters) - :TAKEDA IS SAID TO WEIGH SALE OF SHIRE EYE CARE DRUG TO CUT DEBT - BLOOMBERG, CITING SOURCES. Full Article
Aug 24 (Reuters) - Shire PLC
Aug 23 (Reuters) - U.S. Food And Drug Administration: :U.S. FDA - APPROVED TAKHZYRO, FIRST MONOCLONAL ANTIBODY APPROVED IN U.S. TO TREAT PATIENTS 12 YRS & OLDER WITH TYPES I AND II HEREDITARY ANGIOEDEMA. Full Article
July 10 (Reuters) - Takeda Pharmaceutical Company Ltd <4502.T>::STATEMENT REGARDING US FTC CLEARANCE.TAKEDA RECEIVES CLEARANCE FROM UNITED STATES FEDERAL TRADE COMMISSION FOR PROPOSED ACQUISITION OF SHIRE PLC. Full Article
May 8 (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T> Chief Executive Officer Christophe Weber::NEUROSCIENCE WILL CONTINUE TO BE A CORE AREA.JOBS COULD BE IMPACTED. Full Article
April 25 (Reuters) - Glaxosmithkline
April 25 (Reuters) - GlaxoSmithKline
April 25 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd <4502.T>::SAYS NOTES STATEMENT BY SHIRE PLC REGARDING REVISED PROPOSAL AND EXTENSION OF PUSU DEADLINE TO MAY 8, 2018.SAYS INTENDS TO MAINTAIN ITS WELL-ESTABLISHED DIVIDEND POLICY AND INVESTMENT GRADE CREDIT RATING. Full Article
April 24 (Reuters) - Shire Plc
Sept 21 Bayer AG's long-acting treatment for hemophilia A has won a recommendation from a European Medicines Agency (EMA) panel for the treatment of the rare genetic disorder in which blood does not clot easily.
- Now is the perfect time to buy these 3 healthcare stocks!
- 2 'must-have' healthcare stocks after today's updates?
- Simply the best growth stocks in the FTSE 100?
- Are these 3 Brexit beaters set to fly after today's news?
- Are these 3 stocks due for a serious price correction?
- Should you buy Shire plc, Marks and Spencer Group plc and Amec Foster Wheeler plc following today's news?